4:51 pm · 28 January 2020

US OPEN: Earnings season in full swing, Apple in the spotlight

US100
Indices CFDs
-
-

  • Wall Street set for a strong opening

  • Nasdaq (US100) climbs back above the 9000 pts mark

  • Pfizer, 3M and United Technologies reported Q4 earnings, Apple to report

European indices seesawed between gains and losses during today’s trading. However, US stock markets are expected to open higher with S&P 500 futures pointing to a 0.6% bullish gap at session launch. Earnings season is in full swing with 3M, Pfizer and United Technologies reporting results ahead of the session open. Tech major Apple will publish earnings report after the session close.

Nasdaq (US100) dipped below the lower limit of the Overbalance structure yesterday but managed to recover before hitting support at 8910 pts. The first level to watch should the recovery continue can be found at 30-period exponential moving average (green line, H4 interval). This moving average runs in the vicinity of 9100 pts handle at press time and has acted as a guide for the uptrend over the previous 2 months. Source: xStation5

3M (MMM.US), Pfizer (PFE.US) and United Technologies (UTX.US) are 3 Dow Jones members that reported Q4 earnings ahead of today’s opening bell. Each of those three companies managed to report revenue that was slightly higher than expected (less than 1% higher). However, when it comes to earnings, the situation was not that unambiguous. United Technologies reported EPS of $1.94 - 5.3% higher than expected. On the other hand, Pfizer and 3M disappointed. The former showed an EPS of $0.55 against expected $0.57 while the latter reported EPS of $1.95 against expected $2.10.

Pfizer (PFE.US) has been trading in a steady upward move since mid-August 2019. Earnings miss may exert some pressure on the stock today and if this is the case, support zone ranging near $38.50 handle could come into play. Source: xStation5

Traders should expect elevated volatility on Apple (AAPL.US) today and tomorrow. Manufacturer of iPhones will report earnings for the fourth quarter of 2019 (fiscal Q1 2020) after today’s session close. Company is expected to report EPS of $4.56 (+8.8% YoY) and revenue of $88.38 billion (+4.8% YoY). The stock may also move today in response to a report from Nikkei. The financial newspaper reports that Apple plans to ramp up iPhone production in the first half of 2020 by 10%. However, in a later report Nikkei claimed that this plan may be in danger as coronavirus may disrupt supply chains.

Apple (AAPL.US) has been rallying throughout the previous year and continues to do so in 2020. The stock slumped yesterday as coronavirus concerns arrived at Wall Street. The incoming quarterly report has a chance to be a major market mover as Apple executives may address the impact of coronavirus on supply chains during analyst call. Source: xStation5

17 October 2025, 7:50 pm

3 markets to watch next week - (17.10.2025)

17 October 2025, 6:55 pm

US100 tries to recover🗽Sell-off hits uranium stocks

17 October 2025, 2:23 pm

DE40: European markets decline due to concerns about the U.S. banking sector

17 October 2025, 8:48 am

Morning wrap (17.10.2025)

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Join over 1 700 000 XTB Group Clients from around the world.